Annual report [Section 13 and 15(d), not S-K Item 405]

Revision of previously issued financial statements (unaudited)

v3.26.1
Revision of previously issued financial statements (unaudited)
12 Months Ended
Dec. 31, 2025
Accounting Changes and Error Corrections [Abstract]  
Revision of previously issued financial statements (unaudited)

Note 20 – Revision of previously issued financial statements (unaudited)

 

During the preparation of the Company’s consolidated financial statements for the year ended December 31, 2025, management identified an error related to the valuation method used for its investment position in gold that affected certain previously issued interim unaudited financial statements included in the Company’s quarterly reports on Form 10-Q for the periods ended March 31, 2025, June 30, 2025 and September 30, 2025. The error did not affect any previously issued audited annual financial statements because the Company did not hold an investment position in gold prior to March 17, 2025.

 

The Company evaluated the materiality of the error in accordance with the guidance in ASC 250, “Accounting Changes and Error Corrections,” and Staff Accounting Bulletin No. 99, “Materiality,” and concluded that the impacts were not material, individually or in the aggregate, to our previously issued Consolidated Financial Statements for any of the prior quarters in which they occurred for the periods ended for the periods ended March 31, 2025, June 30, 2025 and September 30, 2025, but that correcting the error in the current period would be material to our results of operations for fiscal year 2025 if it was not corrected. Accordingly, the Company has corrected the error by revising the prior period financial information.

 

The correction of this error had no impact on previously reported audited annual results, and therefore, the Company did not amend its previously filed audited annual reports on Form 10-K. The impact of the revision on the following unaudited interim periods is summarized below.

 

 

Mentor Capital, Inc.

Notes to Consolidated Financial Statements

December 31, 2025 and 2024

 

Impact of revision on previously reported unaudited interim periods:

 

    As Previously Reported     Adjustment(1)     As Restated  
Balance Sheet Impact - March 31, 2025                  
Investment position in gold     302,371       (7,043 )     295,328  
Total current assets     1,780,250       (7,043 )     1,773,207  
Total assets     3,254,505       (7,043 )     3,247,462  
Accumulated deficit     (9,232,027 )     (7,043 )     (9,239,070 )
Total shareholders’ equity     2,687,504       (7,043 )     2,680,461  
Total liabilities and shareholders’ equity     3,254,505       (7,043 )     3,247,462  
                         
Balance Sheet Impact - June 30, 2025                        
Investment position in gold     319,368       (24,040 )     295,328  
Total current assets     1,551,116       (24,040 )     1,527,076  
Total assets     2,991,038       (24,040 )     2,966,998  
Accumulated deficit     (9,448,732 )     (24,040 )     (9,472,772 )
Total shareholders’ equity     2,470,799       (24,040 )     2,446,759  
Total liabilities and shareholders’ equity     2,991,038       (24,040 )     2,966,998  
                         
Balance Sheet Impact - September 30, 2025                        
Investment position in gold     612,328       (95,982 )     516,346  
Total current assets     1,605,105       (95,982 )     1,509,123  
Total assets     3,019,160       (95,982 )     2,923,178  
Accumulated deficit     (9,446,057 )     (95,982 )     (9,542,039 )
Total shareholders’ equity     2,473,474       (95,982 )     2,377,492  
Total liabilities and shareholders’ equity     3,019,160       (95,982 )     2,923,178  

 

(1) The Adjustment is the result of the Company no longer recording its investment in gold at fair market value as a Level 1 investment, ASC 820 “Fair Value Measurement.” The Company’s gold investment was previously valued at fair market value, based on the closing bid price at which it can sell its gold investment back to a broker, using a live quoted price as of March 31, 2025, June 30, 2025, and September 30, 2025. In contrast, the Company now classifies its gold investment as an indefinite-lived nonfinancial asset and accounts for it under a cost model. See Note 2 and Note 11 for further description regarding the accounting treatment.

 

    Quarter ended  
   

March 31,

2025

    June 30,
2025
    September 30, 2025  
Income statement impact by quarter                        
Unrealized gain (loss) on investment in gold - as reported     7,043       16,996       71,943  
Adjustment(1) (unrealized gain/loss)     (7,043 )     (16,996 )     (71,943 )
Unrealized gain (loss) on investment in gold - restated     -       -       -  
                         
Net income - as reported     (204,715 )     (216,705 )     2,675  
Adjustment(1) (unrealized gain/loss)     (7,043 )     (16,996 )     (71,943 )
Net income - restated     (211,758 )     (233,701 )     (69,268 )
                         
Earnings per share impact by quarter                        
Basic earnings per share - as reported     (0.009 )     (0.010 )     0.000123  
Adjustment     (0.001 )     (0.001 )     (0.00332 )
Basic earnings per share - restated     (0.010 )     (0.011 )     (0.00319 )
                         
Diluted earnings per share - as reported     (0.009 )     (0.010 )     0.000107  
Adjustment     (0.001 )     (0.001 )     (0.00330 )
Diluted earnings per share - restated     (0.010 )     (0.011 )     (0.00319 )

 

(1) The Adjustment is the result of the Company no longer recording its investment in gold at fair market value as a Level 1 investment, ASC 820 “Fair Value Measurement.” The Company’s gold investment was previously valued at fair market value, based on the closing bid price at which it can sell its gold investment back to a broker, using a live quoted price as of March 31, 2025, June 30, 2025, and September 30, 2025. In contrast, the Company now classifies its gold investment as an indefinite-lived nonfinancial asset and accounts for it under a cost model. See Note 2 and Note 11 for further description regarding the accounting treatment.